Inotiv (NOTV)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Inotiv (NOTV)
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
Key Insights
Critical company metrics and information
Share Price
$3.80Market Cap
$98.86 MillionTotal Outstanding Shares
26.02 Million SharesTotal Employees
2,075Dividend
No dividendIPO Date
November 25, 1997SIC Description
Services-commercial Physical & Biological ResearchHomepage
https://www.inotivco.com
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $-6.80 Million |
| Net Cash Flow | $-14.06 Million |
| Net Cash Flow From Investing Activities | $-16.83 Million |
| Net Cash Flow, Continuing | $-13.96 Million |
| Net Cash Flow From Investing Activities, Continuing | $-16.83 Million |
| Net Cash Flow From Financing Activities, Continuing | $9.68 Million |
| Net Cash Flow From Financing Activities | $9.68 Million |
| Exchange Gains/Losses | $98000.00 |
| Net Cash Flow From Operating Activities | $-6.80 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Benefits Costs and Expenses | $621.50 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $-108.44 Million |
| Income/Loss From Continuing Operations Before Tax | $-130.76 Million |
| Basic Earnings Per Share | $4.19 |
| Diluted Average Shares | $25.90 Million |
| Revenues | $490.74 Million |
| Net Income/Loss Attributable To Parent | $-108.44 Million |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Net Income/Loss | $-108.89 Million |
| Costs And Expenses | $621.50 Million |
| Operating Income/Loss | $-86.41 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Diluted Earnings Per Share | $4.19 |
| Operating Expenses | $577.14 Million |
| Income Tax Expense/Benefit | $-21.88 Million |
| Basic Average Shares | $25.90 Million |
| Depreciation and Amortization | $57.12 Million |
| Other Operating Expenses | $520.03 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $440000.00 |
| Income/Loss From Continuing Operations After Tax | $-108.89 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Long-term Debt | $393.34 Million |
| Equity | $170.50 Million |
| Other Non-current Assets | $429.62 Million |
| Noncurrent Assets | $617.95 Million |
| Other Non-current Liabilities | $98.48 Million |
| Equity Attributable To Parent | $170.50 Million |
| Accounts Payable | $33.53 Million |
| Fixed Assets | $188.33 Million |
| Other Current Assets | $145.24 Million |
| Inventory | $18.17 Million |
| Liabilities | $610.86 Million |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Current Liabilities | $119.04 Million |
| Assets | $781.36 Million |
| Noncurrent Liabilities | $491.81 Million |
| Liabilities And Equity | $781.36 Million |
| Other Current Liabilities | $85.52 Million |
| Current Assets | $163.41 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.